Lee's Pharmaceutical Holdings Limited (HKG:0950)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.430
+0.010 (0.70%)
May 27, 2025, 4:08 PM HKT
22.22%
Market Cap 836.15M
Revenue (ttm) 1.40B
Net Income (ttm) 93.10M
Shares Out 588.84M
EPS (ttm) 0.16
PE Ratio 8.98
Forward PE n/a
Dividend 0.05 (3.52%)
Ex-Dividend Date May 28, 2025
Volume 107,000
Average Volume 227,400
Open 1.420
Previous Close 1.420
Day's Range 1.420 - 1.450
52-Week Range 1.060 - 1.600
Beta 0.75
RSI 64.68
Earnings Date May 23, 2025

About HKG:0950

Lee's Pharmaceutical Holdings Limited, an investment holding company, develops, manufactures, markets, and sells pharmaceutical products primarily in the People's Republic of China. It focuses on various disease areas, such as cardiovascular, woman’s health, paediatrics, rare diseases, oncology, dermatology, and obstetrics. It operates through Proprietary and Generic Products; and Licensed-In Products segments. The Proprietary and Generic Products segment manufactures and sells self-developed and generic pharmaceutical products, such as Nadropa... [Read more]

Sector Healthcare
Founded 1994
Employees 1,022
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 0950
Full Company Profile

Financial Performance

In 2024, HKG:0950's revenue was 1.40 billion, an increase of 32.95% compared to the previous year's 1.05 billion. Earnings were 93.10 million, an increase of 457.55%.

Financial Statements

News

There is no news available yet.